@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RA5Etq-UKh4Ojh9-7bsQcmoAj6okQ9o0u2CfsyvU2swjQ> .
@prefix sub: <http://purl.org/np/RA5Etq-UKh4Ojh9-7bsQcmoAj6okQ9o0u2CfsyvU2swjQ#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:mz6nyisw&rows=> .
@prefix ns1: <http://wordnet-rdf.princeton.edu/lemma/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubInfo ;
    a np:Nanopublication .
}
sub:assertion {
  <https://uts.nlm.nih.gov/uts/umls/concept/C0003374> ns1:use <https://uts.nlm.nih.gov/uts/umls/concept/C5203670> .
}
sub:provenance {
  sub:assertion prov:generatedAtTime "2021-12-16T20:10:56.255493"^^xsd:dateTime ;
    prov:wasGeneratedBy "S&T TWOC project version 2" .
  sub:version prov:value 2 .
  rdf:OBJECT rdfs:label "as off-label medications to treat COVID-19" .
  rdf:OBJECT-POSITION rdfs:label 252 .
  rdf:PREDICATE rdfs:label "used" .
  rdf:PREDICATE-POSITION rdfs:label "[189]" .
  rdf:SUBJECT rdfs:label "Certain medications , for example , dexamethasone , antimalarials ( chloroquine / hydroxychloroquine ) , antiviral ( remdesivir ) , and IL-6 receptor blocking monoclonal antibodies ( tocilizumab )" .
  rdf:SUBJECT-POSITION rdfs:label 51 .
  rdfs:ABSTRACT-UID ns2:50 "mz6nyisw" .
  rdfs:SENTENCE rdfs:label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." .
  rdfs:TRIPLE-UID ns3:mz6nyisw-TRIPLE-ABSTRACT-1 "mz6nyisw-TRIPLE-ABSTRACT-1" .
  <https://uts.nlm.nih.gov/uts/umls/concept/C0003374> rdfs:label "antimalarials" .
  <https://uts.nlm.nih.gov/uts/umls/concept/C5203670> rdfs:label "covid-19" .
}
sub:pubInfo {
  sub:assertion prov:wasDerivedFrom <https://doi.org/10.1007/s10787-020-00744-0> .
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" ;
    npx:hasSignature "RQmE+MA9+W/8x8juBFt9Vv/MEvGJMHsgRy5k7FIW6eKgkXb9gpGZXX+l5uDI7MRYNLeYaiT9DyATxT+dueE2c7Te8sfM0zIokSFi6itzru63pywc3/TqLJSrkZj9I5d4L/+BSMkN4xR+c8Ot2C3J23B0XDp+M5T/D5ihkKTYTxQ=" ;
    npx:hasSignatureTarget this: .
  this: prov:generatedAtTime "2021-12-16T20:10:56.255493"^^xsd:dateTime ;
    prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}